Brief Summary

A cross-sectional study describing the current status of diagnosis and treatment of uroepithelial cancer in hospitals of different grades in Henan Province

Trial Health

At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date

Enrollment

400

participants targeted

Target at P75+ for all trials

Timeline

Completed

Started Oct 2024

Shorter than P25 for all trials

Geographic Reach

1 country

11 active sites

Status

not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

9 months study duration

First Submitted

Initial submission to the registry

October 21, 2024

Completed

8 days until next milestone

First Posted

Study publicly available on registry

October 29, 2024

Completed

1 day until next milestone

Study Start

First participant enrolled

October 30, 2024

Completed

9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 31, 2025

Completed

Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 31, 2025

Completed

Last Updated

October 29, 2024

Status Verified

October 1, 2024

Enrollment Period

9 months

First QC Date

October 21, 2024

Last Update Submit

October 27, 2024

Conditions

Uroepithelial Carcinoma

Keywords

Henan provinceuroepithelial cancertreatment

Outcome Measures

Primary Outcomes (1)

Describing the diagnosis and treatment patterns of patients with early versus advanced uroepithelial carcinoma in different grades of hospitals in Henan Province
To describe the similarities and differences between the way patients with early and advanced uroepithelial cancer are diagnosed and treated in different levels of hospitals in Henan Province and the current guidelines for uroepithelial cancer.
up to the patients enrolled,an average of 1 year

Secondary Outcomes (2)

Comparison of differences in diagnosis and treatment patterns between patients with early-stage and advanced uroepithelial carcinoma in county hospitals and different consultation departments of the same hospital in Henan province
up to the patients enrolled,an average of 1 year
Describing the pathology as well as genetic testing of patients with uroepithelial carcinoma in different grades of hospitals in Henan province
up to the patients enrolled,an average of 1 year

Study Arms (2)

Diagnosis and management of patients with early stage resectable uroepithelial carcinoma

The study is a multicenter, non-interventional, observational cross-sectional study. It is planned to enroll patients with early stage resectable uroepithelial cancer in each study hospital in Henan Province. This is a cross-sectional study, and all patients will be anonymized for clinical data collection, and detailed information on patient demographic characteristics as well as medical and treatment history, hospitals at different stages of treatment, pathological test results, and medication regimens will be recorded at the beginning of enrollment.

Diagnosis and management of patients with advanced unresectable uroepithelial cancer

It is planned to enroll patients with advanced unresectable uroepithelial cancer in each study hospital in Henan Province. This is a cross-sectional study, and all patients will be anonymized for clinical data collection, and detailed information on patient demographic characteristics as well as medical and treatment history, hospitals at different stages of treatment, pathological test results, and medication regimens will be recorded at the beginning of enrollment.

Eligibility Criteria

Age18 Years - 75 Years

Sexall

Healthy VolunteersNo

Age GroupsAdult (18-64), Older Adult (65+)

Sampling MethodProbability Sample

Study Population

Patients diagnosed with uroepithelial carcinoma attending multiple research center hospitals in Henan Province from January 1, 2023-December 31, 2023

You may qualify if:

Adults ≥18 years of age (at enrollment)
Histologically confirmed uroepithelial carcinoma
Patients with newly diagnosed or completed radical uroepithelial carcinoma in the early stages of uroepithelial cancer/advanced unresectable or with distant metastases of urothelial carcinoma
Complete medical history information

You may not qualify if:

Incomplete medical history and medical records

Contact the study team to confirm eligibility.

Sponsors & Collaborators

The First Affiliated Hospital of Xinxiang Medical Collegelead

Study Sites (11)

Kaifeng City Center Hospital

Kaifeng, Henan, 453000, China

Location

Luoyang Renda Hospital

Luoyang, Henan, 450000, China

Location

Nanyang City Center Hospital

Nanyang, Henan, 450000, China

Location

Qingfeng County People's Hospital

Puyang, Henan, 450000, China

Location

Department of Oncology

Xinxiang, Henan, 453100, China

Location

Hui County People's Hospital